CO5200779A1 - Composiciones y metodos para tratar condiciones alergicas e inflamatorias con tos rgicas e inflamatorias con tos - Google Patents

Composiciones y metodos para tratar condiciones alergicas e inflamatorias con tos rgicas e inflamatorias con tos

Info

Publication number
CO5200779A1
CO5200779A1 CO00061954A CO00061954A CO5200779A1 CO 5200779 A1 CO5200779 A1 CO 5200779A1 CO 00061954 A CO00061954 A CO 00061954A CO 00061954 A CO00061954 A CO 00061954A CO 5200779 A1 CO5200779 A1 CO 5200779A1
Authority
CO
Colombia
Prior art keywords
inflammatory
methods
inflammatory conditions
rgic
compositions
Prior art date
Application number
CO00061954A
Other languages
English (en)
Inventor
Lugo Sergio Rolando Ulloa
Ramos Jose De Jesus Villacampa
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CO5200779A1 publication Critical patent/CO5200779A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen métodos para tratar y/o prevenir condiciones alérgicas e inflamatorias con tos en humanos que requieran dicho tratamiento y/o prevención, los cuales comprenden administrar una cantidad efectiva de una antihistamina no sedante en combinación con un expectorante; las modalidades que se prefieren incluyen aquellas en las que la antihistamina no sedante es loratadina y el expectorante es ambroxol; se proveen también composiciones farmacéuticas novedosas para tratar y/o prevenir condiciones alérgicas e inflamatorias con tos en humanos, las cuales comprenden una cantidad efectiva de una antihistamina no sedante en combinación con un expectorante y un vehículo farmacéuticamente aceptable.
CO00061954A 2000-03-30 2000-08-17 Composiciones y metodos para tratar condiciones alergicas e inflamatorias con tos rgicas e inflamatorias con tos CO5200779A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19331000P 2000-03-30 2000-03-30

Publications (1)

Publication Number Publication Date
CO5200779A1 true CO5200779A1 (es) 2002-09-27

Family

ID=22713096

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00061954A CO5200779A1 (es) 2000-03-30 2000-08-17 Composiciones y metodos para tratar condiciones alergicas e inflamatorias con tos rgicas e inflamatorias con tos

Country Status (13)

Country Link
CN (1) CN1422162A (es)
AR (1) AR025308A1 (es)
AU (2) AU4786701A (es)
BR (1) BR0003648A (es)
CO (1) CO5200779A1 (es)
CR (1) CR6232A (es)
NZ (1) NZ520826A (es)
PA (1) PA8500101A1 (es)
PE (1) PE20010576A1 (es)
SG (1) SG96611A1 (es)
TW (1) TWI243671B (es)
WO (1) WO2001074341A2 (es)
ZA (1) ZA200102605B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1323662C (zh) * 2004-06-18 2007-07-04 江苏恒瑞医药股份有限公司 含有氨溴索和厄多司坦或乙酰半胱氨酸的药物组合物及其应用
WO2005123052A1 (fr) * 2004-06-18 2005-12-29 Jiangsu Hengrui Medicine Co., Ltd. Composition medicamenteuse contenant de l'ambroxol et de l'erdosteine ou de l'acetylcysteine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
AU7604094A (en) * 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
US6160020A (en) * 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen

Also Published As

Publication number Publication date
CN1422162A (zh) 2003-06-04
WO2001074341A2 (en) 2001-10-11
BR0003648A (pt) 2002-01-02
CR6232A (es) 2008-12-01
ZA200102605B (en) 2001-10-03
AU4786701A (en) 2001-10-15
PE20010576A1 (es) 2001-05-08
AR025308A1 (es) 2002-11-20
WO2001074341A3 (en) 2002-05-16
TWI243671B (en) 2005-11-21
AU2001247867B2 (en) 2005-09-01
NZ520826A (en) 2004-07-30
SG96611A1 (en) 2003-06-16
PA8500101A1 (es) 2002-09-17

Similar Documents

Publication Publication Date Title
UY28041A1 (es) Metodos de dosis bajas para el tratamiento de trastornos en los cuales la actividad del tnfa es perjudicial.
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
CY1114133T1 (el) ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ
CR6210A (es) Composiciones de celecoxib
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
DK1257550T3 (da) Blodplade-ADP-receptor-inhibitor
ES2176600T3 (es) Derivado de la propiofenona y procedimientos para su preparacion.
UY26130A1 (es) Compuestos para tratar la obesidad
NO993847D0 (no) Fremgangsmåter og sammensetninger for behandling av allergisk astma og andre sykdommer som anvender deskarboetoksyloratadin
DK0682664T3 (da) Forbindelser med både potent calciumantagonist og antioxiderende aktivitet og anvendelse deraf som cytobeskyttende midler
NO20034094L (no) Sammensetninger som omfatter et antidiar±middel og et epotilon eller et epotilonderivat
ES2177112T3 (es) Agentes angiostaticos y composiciones para tratar el glaucoma glc1a.
AR008799A1 (es) Composicion de vacuna para prevenir o tratar el paludismo; uso de dicha composicion para elaborar medicamentos y metodo para dicha profilaxis y dichotratamiento
ECSP003807A (es) Composiciones valdecoxib
ECSP045153A (es) Metodo y composición para aumentar la potencia de un analgésico de narcotico.
ES2183817T3 (es) Inibidores de proteasas de parasatiso metazoarios.
CY1106800T1 (el) Μεθοδοι και συνθεσεις δια χρησιμοποιησεως μεταβολιτων τepφεναδινης εν συνδυασμω μετ’ αναστολεων λευκοτριενιου
CO5160295A1 (es) Nuevas combinaciones farmaceuticas para inhibidores de la nos cionalmente un ssri
AR028502A1 (es) Tratamiento de condiciones inflamatorias alérgicas
PA8525801A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2
CO5200779A1 (es) Composiciones y metodos para tratar condiciones alergicas e inflamatorias con tos rgicas e inflamatorias con tos
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
UY26648A1 (es) Inhibidores de vasopeptidasa para tratar hipertensión sistólica aislada

Legal Events

Date Code Title Description
FC Application refused